US Patent 9169310 Glucagon analogues
Patent 9169310 was granted and assigned to Zealand Pharma A/S on October, 2015 by the United States Patent and Trademark Office.
All edits
Edits on 1 Feb, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 3 Dec, 2023
Golden AI
Edits made to:
Article (+416 characters)
Article
Patent abstract
The invention provides materials and methods for promoting weight loss or preventing weight gain and for treating diabetes and associated metabolic disorders. In particular, the invention provides novel glucagon analogue peptide compounds effective in such methods. The compounds may mediate their effect by having, for example, increased selectivity for the GLP-1 receptor compared to human glucagon.
Edits on 15 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09169310 Glucagon analogues US Patent 9169310 Glucagon analogues
Infobox
Patent Number
091693100
Patent Number
91693100
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 5 Oct, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
091693100
Date of Patent
October 27, 2015
0Patent Application Number
137042990
Date Filed
June 24, 2011
0Official Website
Patent Primary Examiner
Edits on 8 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 3 Jan, 2022
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 09169310 Glucagon analogues
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
09169310
Date of patent
October 27, 2015
Patent application number
13704299
Date Filed
June 24, 2011
Patent primary examiner
Find more entities like US Patent 9169310 Glucagon analogues
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
